Market Closed -
Bombay S.E.
06:00:50 2024-05-03 am EDT
|
5-day change
|
1st Jan Change
|
820.8
INR
|
-0.53%
|
|
-2.34%
|
+7.05%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
14,002
|
8,658
|
6,592
|
12,905
|
31,350
|
19,006
|
Enterprise Value (EV)
1 |
21,826
|
18,004
|
16,548
|
24,239
|
41,745
|
30,109
|
P/E ratio
|
14.5
x
|
6.53
x
|
5.75
x
|
9.81
x
|
9.22
x
|
15.2
x
|
Yield
|
0.88%
|
2.15%
|
2.82%
|
1.44%
|
0.74%
|
1.22%
|
Capitalization / Revenue
|
0.46
x
|
0.26
x
|
0.19
x
|
0.56
x
|
1.09
x
|
0.72
x
|
EV / Revenue
|
0.72
x
|
0.54
x
|
0.47
x
|
1.05
x
|
1.46
x
|
1.14
x
|
EV / EBITDA
|
6.71
x
|
3.96
x
|
3.87
x
|
8.73
x
|
15.9
x
|
9.43
x
|
EV / FCF
|
10.3
x
|
-22.9
x
|
13.7
x
|
-6.72
x
|
-253
x
|
-13.7
x
|
FCF Yield
|
9.71%
|
-4.38%
|
7.28%
|
-14.9%
|
-0.4%
|
-7.3%
|
Price to Book
|
1.66
x
|
0.9
x
|
0.64
x
|
1.1
x
|
1.75
x
|
1
x
|
Nbr of stocks (in thousands)
|
30,962
|
30,962
|
30,962
|
30,962
|
30,962
|
30,962
|
Reference price
2 |
452.2
|
279.6
|
212.9
|
416.8
|
1,013
|
613.8
|
Announcement Date
|
7/12/18
|
7/27/19
|
8/31/20
|
8/31/21
|
8/12/22
|
8/18/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
30,343
|
33,566
|
34,910
|
23,170
|
28,683
|
26,509
|
EBITDA
1 |
3,253
|
4,548
|
4,274
|
2,778
|
2,621
|
3,193
|
EBIT
1 |
2,522
|
3,785
|
3,503
|
2,036
|
1,872
|
2,345
|
Operating Margin
|
8.31%
|
11.28%
|
10.03%
|
8.79%
|
6.53%
|
8.85%
|
Earnings before Tax (EBT)
1 |
1,472
|
2,131
|
1,739
|
1,205
|
3,690
|
1,650
|
Net income
1 |
965.3
|
1,326
|
1,147
|
1,316
|
3,399
|
1,251
|
Net margin
|
3.18%
|
3.95%
|
3.28%
|
5.68%
|
11.85%
|
4.72%
|
EPS
2 |
31.18
|
42.83
|
37.03
|
42.51
|
109.8
|
40.40
|
Free Cash Flow
1 |
2,120
|
-787.9
|
1,205
|
-3,609
|
-165.1
|
-2,198
|
FCF margin
|
6.99%
|
-2.35%
|
3.45%
|
-15.58%
|
-0.58%
|
-8.29%
|
FCF Conversion (EBITDA)
|
65.16%
|
-
|
28.19%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
219.58%
|
-
|
105.06%
|
-
|
-
|
-
|
Dividend per Share
2 |
4.000
|
6.000
|
6.000
|
6.000
|
7.500
|
7.500
|
Announcement Date
|
7/12/18
|
7/27/19
|
8/31/20
|
8/31/21
|
8/12/22
|
8/18/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
7,824
|
9,346
|
9,956
|
11,334
|
10,395
|
11,103
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.405
x
|
2.055
x
|
2.33
x
|
4.08
x
|
3.965
x
|
3.477
x
|
Free Cash Flow
1 |
2,120
|
-788
|
1,205
|
-3,609
|
-165
|
-2,198
|
ROE (net income / shareholders' equity)
|
12.1%
|
14.7%
|
11.5%
|
9.92%
|
22.4%
|
7.68%
|
ROA (Net income/ Total Assets)
|
4.56%
|
6.57%
|
5.56%
|
3.1%
|
2.67%
|
3.09%
|
Assets
1 |
21,167
|
20,196
|
20,612
|
42,424
|
127,095
|
40,488
|
Book Value Per Share
2 |
273.0
|
311.0
|
334.0
|
377.0
|
579.0
|
614.0
|
Cash Flow per Share
2 |
1.620
|
8.710
|
1.180
|
1.100
|
2.280
|
0.6400
|
Capex
1 |
1,295
|
1,392
|
1,550
|
1,489
|
3,799
|
4,388
|
Capex / Sales
|
4.27%
|
4.15%
|
4.44%
|
6.43%
|
13.25%
|
16.55%
|
Announcement Date
|
7/12/18
|
7/27/19
|
8/31/20
|
8/31/21
|
8/12/22
|
8/18/23
|
|
1st Jan change
|
Capi.
|
---|
| +7.05% | 305M | | +2.56% | 102B | | -1.92% | 66.01B | | +47.62% | 41.76B | | +15.99% | 38.66B | | +4.25% | 32.28B | | +8.78% | 19.57B | | +12.32% | 16.77B | | +17.69% | 15.08B | | +8.31% | 14.83B |
Other Commodity Chemicals
|